T. Rowe Price Investment Management
ETNB

T. Rowe Price Investment Management’s 89bio ETNB Stock Holding History

T. Rowe Price Investment Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,047
Closed -$31K – 918
2025
Q3 		$31K Buy
2,047
+1,073
+110% +$10.9K ﹤0.01% 668
2025
Q2 		$10K Buy
+974
New +$8.06K ﹤0.01% 675

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

T. Rowe Price Investment Management's ETNB Position: Q4 2025 in Review

T. Rowe Price Investment Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 2,047 shares — an estimated $31K sold.

T. Rowe Price Investment Management first reported a position in ETNB in Q2 2025 and held it in 2 quarters. The position peaked at $31K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • T. Rowe Price Investment Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 2,047 89bio shares in Q4 2025, an estimated $31K.
  • T. Rowe Price Investment Management first reported a position in 89bio in Q2 2025 and held it in 2 quarters.
  • T. Rowe Price Investment Management's 89bio position peaked at $31K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.